Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Rickenbach

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Archives of Internal Medicine|October 15, 2003
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort StudyGilbert R Kaufmann, Luc Perrin, Guiseppe Pantaleo, et al.
Blood|April 2, 2009
Hodgkin lymphoma in the Swiss HIV Cohort StudyGary M Clifford, Martin Rickenbach, Mauro Lise, et al.
AIDS (London, England)|December 22, 2007
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyJerry Polesel, Gary M Clifford, Martin Rickenbach, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2002
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort StudyEnos Bernasconi, Karim Boubaker, Cornelia Junghans, et al.
Lancet (London, England)|September 19, 2003
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general populationChristian Jaggy, Jan von Overbeck, Bruno Ledergerber, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2013
Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal deliveryKaroline Aebi-Popp, Fiona Mulcahy, Tracy R Glass, et al.
Journal of the National Cancer Institute|March 17, 2005
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapyGary M Clifford, Jerry Polesel, Martin Rickenbach, et al.
Journal of the International AIDS Society|November 14, 2014
Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D studyCamilla Ingrid Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.
AIDS (London, England)|November 7, 2015
Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortalityTracy R Glass, Jonathan A C Sterne, Marie-Paule Schneider, et al.
The Journal of Infectious Diseases|April 6, 2005
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disordersPhilip E Tarr, Patrick Taffé, Gabriela Bleiber, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Archives of Internal Medicine|October 15, 2003
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort StudyGilbert R Kaufmann, Luc Perrin, Guiseppe Pantaleo, et al.
Blood|April 2, 2009
Hodgkin lymphoma in the Swiss HIV Cohort StudyGary M Clifford, Martin Rickenbach, Mauro Lise, et al.
AIDS (London, England)|December 22, 2007
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyJerry Polesel, Gary M Clifford, Martin Rickenbach, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2002
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort StudyEnos Bernasconi, Karim Boubaker, Cornelia Junghans, et al.
Lancet (London, England)|September 19, 2003
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general populationChristian Jaggy, Jan von Overbeck, Bruno Ledergerber, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2013
Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal deliveryKaroline Aebi-Popp, Fiona Mulcahy, Tracy R Glass, et al.
Journal of the National Cancer Institute|March 17, 2005
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapyGary M Clifford, Jerry Polesel, Martin Rickenbach, et al.
Journal of the International AIDS Society|November 14, 2014
Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D studyCamilla Ingrid Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.
AIDS (London, England)|November 7, 2015
Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortalityTracy R Glass, Jonathan A C Sterne, Marie-Paule Schneider, et al.
The Journal of Infectious Diseases|April 6, 2005
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disordersPhilip E Tarr, Patrick Taffé, Gabriela Bleiber, et al.
Pageof 7